Current biologics in treatment of pemphigus foliaceus: a systematic review

BackgroundPemphigus foliaceus (PF) differs from pemphigus vulgaris (PV) in that it affects only the skin and mucous membranes are not involved. Pemphigus is commonly treated with systemic corticosteroids and immunosuppressive agents (ISAs). More recently, biologics have been used. The current litera...

Full description

Bibliographic Details
Published in:Frontiers in Immunology
Main Authors: Caden A. Carver, Mikole Kalesinskas, A. Razzaque Ahmed
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-10-01
Subjects:
pemphigus foliaceus
pemphigus vulgaris
rituximab
intravenous immunoglobulin
biologics
systemic corticosteroids
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2023.1267668/full

Internet

https://www.frontiersin.org/articles/10.3389/fimmu.2023.1267668/full

Similar Items